Literature DB >> 28874866

Reply to Huang et al.

Young Eun Chon1, Jun Yong Park2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28874866     DOI： 10.1038/ajg.2017.223

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  5 in total

1.  Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.

Authors:  W Ray Kim; Thomas Berg; Tarik Asselah; Robert Flisiak; Scott Fung; Stuart C Gordon; Harry L A Janssen; Pietro Lampertico; Daryl Lau; Jeffrey D Bornstein; Raul E Aguilar Schall; Phillip Dinh; Leland J Yee; Eduardo B Martins; Seng Gee Lim; Rohit Loomba; Jörg Petersen; Maria Buti; Patrick Marcellin
Journal:  J Hepatol       Date:  2015-12-02       Impact factor: 25.083

2.  Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).

Authors:  Kyu Sik Jung; Seung Up Kim; Sang Hoon Ahn; Young Nyun Park; Do Young Kim; Jun Yong Park; Chae Yoon Chon; Eun Hee Choi; Kwang-Hyub Han
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

3.  "Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population.

Authors:  Beom Kyung Kim; Seung Up Kim; Gi Hong Choi; Woong Kyu Han; Mi Sung Park; Eun Hye Kim; Jun Yong Park; Do Young Kim; Jin Sub Choi; Seung Choul Yang; Eun Hee Choi; Kijun Song; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon
Journal:  J Gastroenterol Hepatol       Date:  2012-04       Impact factor: 4.029

4.  Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B.

Authors:  Patrick Marcellin; Marianne Ziol; Pierre Bedossa; Catherine Douvin; Raoul Poupon; Victor de Lédinghen; Michel Beaugrand
Journal:  Liver Int       Date:  2008-07-09       Impact factor: 5.828

Review 5.  Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.

Authors:  Jun Hyung Kim; Mi Na Kim; Kwang-Hyub Han; Seung Up Kim
Journal:  Liver Int       Date:  2014-07-19       Impact factor: 5.828
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.